Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from ...
Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...
Siemens Healthineers, India’s recent partnership with HealthCare Global Enterprises (HCG), is aimed to revolutionize cancer ...
Bayer seeks European approval for darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, October 16, 2024, 13:00 Hrs [IST] ...
Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, ...
The phase 3 trial AMPLIFY study plans to test the diagnostic performance of 64Cu-SAR-bisPSMA PET/CT imaging in approximately ...
In this feature we spoke to Michael J. Morris, MD, and Benjamin Garmezy, MD, on the future of radioligand therapy in patients ...
Clarity Pharmaceuticals Dr Alan Taylor Catherine Strong Executive Chairman Investor/Media Relations ataylor@claritypharm.
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
Developing new cancer treatment tools, using imaging techniques such as PET-CT and MRI, and new radiopharmaceuticals for next-generation personalized therapies ("Theranostics") to target cancer first ...
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Australian Therapeutic Goods Administration (TGA) has approved the use of Illuccix® (kit for the preparation of ...
Study shows new imaging technique accurately detects aggressive kidney cancer: Los Angeles, California Monday, October 7, 2024, 18:00 Hrs [IST] A new study led by investigators fr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback